Cadwalader is pleased to announce it is representing Cigna Corporation in connection with the antitrust clearance for its $54.2 billion merger with Anthem, Inc.
The firm is advising P&G on tax aspects of the merger of 43 of its beauty brands with Coty in a Reverse Morris Trust transaction.
The initiative will focus on counseling and defending health care systems, life sciences companies and providers faced with False Claims Act and other fraud and abuse matters.
The firm was recognized for its work with Eli Lilly & Company in connection with its acquisition of Novartis Animal Health. It marks Cadwalader's second Matter of the Year win in a row.
Cadwalader was recognized by Trading Risk as 2014 Non-Life Transaction of the Year for Lion I Re, a groundbreaking catastrophe bond sponsored by Assicurazioni Generali S.p.A.
Cadwalader Advises Canada Pension Plan Investment Board in Connection with its Acquisition of Antares Capital from GE Capital Corporation
Cadwalader’s Capital Markets, Tax and Corporate practices provided advice to the professional investment management organization in connection with the financing of the $12 billion transaction.
Firm advised UBS and HSBC as underwriters on the inaugural CHF250 million bond offering by Sinochem Offshore Capital Company Limited.
Advisor brings unique perspective in representing both corporate boards and hedge funds in activist campaigns, contests for corporate control and proxy contests.